AstraZeneca Expands Use of InnaPhase Watson(TM) Laboratory Information Management System in the United Kingdom.

PHILADELPHIA -- PHILADELPHIA, June 4 /PRNewswire/ -- InnaPhase Corporation, a leading provider of LIMS solutions for the life sciences, today announced that AstraZeneca has implemented the Watson(TM) Laboratory Information Management System (LIMS) in their Adlerley Park Research and Development Center based in the United Kingdom. AstraZeneca is also using the Watson LIMS product within their facilities in Charnwood, United Kingdom, Lund, Sweden and Wilmington, Delaware in the United States.

Watson LIMS, a solution within the Pharma LIMS(TM) Suite, is specifically designed to support DMPK/Bioanalytical studies in drug development while ensuring regulatory compliance with the FDA's 21 CFR Part 11 guidance on electronic records and signatures. Watson has an established track record of accelerating bioanalysis, sample management and regulatory compliance in pharmaceutical drug development.

"AstraZeneca has one of the best new product pipelines in the industry," said Dave Sweetmore, Business Project Manager. "By using innovative technology such as Watson LIMS, we will enable our scientists to make more rapid and informed decisions in order to continue to produce the highest quality of results possible."

"We are pleased that AstraZeneca has chosen to expand their use of Watson," said Jo Webber, Ph.D., President and CEO of InnaPhase Corporation. "I am certain that Watson will provide AstraZeneca with significant cost savings and a quick return on their ...